Brian Jao, MD
Plastic and Reconstructive Surgery · Kansas City, MONPI 1932561487
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (39.5%), education and travel and lodging — rather than concentrated in one kind of arrangement. 11 manufacturers reported payments, led by Arthrex at 32.6% of the total. Reporting peaked in 2023 at $1,995 and has fallen 87.5% since, to $250 in 2025.
Across 42 payments — averaging $88.89 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Arthrex$1K
- Pylant Medical$1K
- Axogen$774
- Endo Pharmaceuticals Inc.$147
- TELA Bio, Inc.$106
- Mentor Worldwide LLC$73
- plus $216 from 5 others
What the payments were for
- Travel & lodging$1,05928%
- Food & beverage$1,47539%
- Education$1,20032%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Arthrex | 14 | $1,218 |
| Pylant Medical | 1 | $1,200 |
| Axogen | 16 | $774 |
| Endo Pharmaceuticals Inc. | 1 | $147 |
| TELA Bio, Inc. | 1 | $106 |
| Mentor Worldwide LLC | 3 | $73 |
| Integra Lifesciences Corporation | 1 | $67 |
| AbbVie | 1 | $60 |
| Stryker | 2 | $40 |
| Aroa Biosurgery Incorporated | 1 | $33 |
| Titan Surgical Group, LLC | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,734 in reported general payments places this provider in the 55th percentile of 61 plastic and reconstructive surgery providers in Missouri.
See all plastic and reconstructive surgery providers in Missouri →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Oxycodone Hcl | 51 | $189 |
| Cefadroxil | 13 | $114 |
Paid to pharmacies, not to this prescriber.
Other plastic and reconstructive surgery in Kansas City
- Carlos MartinezKansas City$4K
- Carol Ann AylwardKansas City$2K
- Adam GoodreauKansas City$1K
- Jeffrey GoldsteinKansas City$220
- Lindsay PowersKansas City$188
- Terence MyckatynSaint Louis$399K
- David CaplinSaint Louis$81K
- Patricia McGuireSaint Louis$66K
- Bruce KraemerSt Louis$53K
- Mitchell PetSaint Louis$42K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.